Increased urinary endothelin excretion in patients with liver cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 4, 1996, Pages 347-352

  Kitano, M ^a   Uemasu, J ^a   Kawasaki, H ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

liver cirrhosis; renal kallikrein kinin system; urinary endothelin

Indexed keywords

ENDOTHELIN;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KALLIKREIN KININ SYSTEM; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; URINALYSIS;

EID: 0030012029     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb01382.x     Document Type: Article

References (33)

1. 1 Henriksen JH, Ring‐Larsen H., Kanstrup IL, Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 1984 ; 25: 1034–43.
2. 2 Arroyo V., Bosch J., Mauri M. et al. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites. Eur. J. Clin. Invest. 1979 ; 9: 69–73.
3. 3 Bichet D., Szatalowicz V., Chaimovitz C., Schrier RW. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann. Intern. Med. 1982 ; 96: 413–17.
4. 4 Kawasaki H., Murawaki Y., Hirayama C. Urinary kallikrein excretion in chronic liver disease and effect of indomethacin. Am. J. Gastroenterol. 1986 ; 81: 67–70.
5. 5 Kawasaki H., Uemasu J., Maeda N., Hirayama C., Kobayashi T., Sakurai H. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease. Am. J. Gastroenterol. 1987 ; 82: 727–31.
6. 6 Yanagisawa M., Kurihara H., Kimura S. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988 ; 332: 411–15.
7. 7 Schrader J., Tebbe U., Borries M. et al. Plasma‐Endothelin bei Normalpersonen und Patienten mit nephrologisch‐rheumatologischen und kardiovaskularen Erkrankungen. Klin. Wochenschr. 1990 ; 68: 774–9.
8. 8 Uemasu J., Matsumoto H., Kawasaki H. Increased plasma endothelin levels in patients with liver cirrhosis. Nephron 1992 ; 60: 380.
9. 9 Uchihara M., Izumi N., Sato C., Marumo F. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992 ; 16: 95–9.
10. 10 Asbert M., Gines A., Gines P. et al. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993 ; 104: 1485–91.
11. 11 Mollers S., Emmeluth C., Henriksen JH et al. Elevated circulating plasma endothelin‐1 concentrations in cirrhosis. J. Hepatol. 1993 ; 19: 285–90.
12. 12 Matsumoto H., Uemasu J., Kitano M., Kawasaki H. Clinical significance of plasma endothelin‐1 in patients with chronic liver disease. Dig. Dis. Sci. 1994 ; 39: 2665–70.
13. 13 Lerman A., Click RL, Narr BJ et al. Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. Transplantation 1991 ; 51: 646–50.
14. 14 Veglio F., Pinna G., Melchio R. et al. Plasma endothelin level in cirrhotic subjects. J. Hepatol. 1992 ; 15: 85–7.
15. 15 King AJ, Brenner BM, Anderson S. Endothelin: A potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 1989 ; 256: F1051–8.
16. 16 Miller WL, Redfield MM, Burnett JC. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 1989 ; 83: 317–20.
17. 17 Banks RO. Effects of endothelin on renal function in dogs and rats. Am. J. Physiol. 1990 ; 258: F775–80.
18. 18 Sakamoto H., Sasaki S., Hirata Y. et al. Production of endothelin by rat cultured mesangial cells. Biochem. Biophys. Res. Commun. 1990 ; 169: 462–8.
19. 19 Ohta K., Hirata Y., Imai T. et al. Cytokine‐induced release of endothelin‐1 from porcine renal epithelial cell line. Biochem. Biophys. Res. Commun. 1990 ; 169: 578–84.
20. 20 Kohan DE. Endothelin synthesis by rabbit renal tubule cells. Am. J. Physiol. 1991 ; 261: F221–6.
21. 21 Simonson MS, Wann S., Mene P. et al. Endothelin stimulates phospholipase C, Na + /H + exchange, c‐fos expression and mitogenesis in rat mesangial cells. J. Clin. Invest. 1989 ; 83: 708–12.
22. 22 Karet FE, Kuc RE, Davenport AV. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ET A and ET B in human kidney. Kidney Int. 1993 ; 44: 36–42.
23. 23 Ohta K., Hirata Y., Shichiri M. et al. Urinary excretion of endothelin‐1 in normal subjects and patients with renal disease. Kidney Int. 1991 ; 39: 307–11.
24. 24 Benigni A., Perico N., Ladny JR et al. Increased urinary excretion of endothelin‐1 and its precursor, bigendothelin‐1, in rats chronically treated with cyclosporine. Transplantation 1991 ; 52: 175–7.
25. 25 Yoshida H., Nakamura M. Inhibition by angiotensin converting enzyme inhibitors of endothelin secretion from cultured human endothelial cells. Life Sci. 1992 ; 50: PL195–200.
26. 26 Marsden PA, Dorfman DM, Collins T., Brenner BM, Orkin SH, Ballermann BJ. Regulated expression of endothelin in glomerular capillary endothelial cells. Am. J. Physiol. 1991 ; 261: F117–25.
27. 27 Kohno M., Yasunari K., Nagai K. et al. Plasma immunoreactive endothelin in essential hypertension. Am. J. Med. 1990 ; 88: 614–18.
28. 28 Ishibashi M., Fujita M., Nagai K. et al. Production and secretion and endothelin by hepatocellular carcinoma. J. Clin. Endocrinol. Metab. 1993 ; 76: 378–83.
29. 29 Nakamuta M., Ohashi M., Tabata S. et al. High plasma concentrations of endothelin‐like immunoreactivities in patients with hepatocellular carcinoma. Am. J. Gastroenterol. 1993 ; 88: 245–52.
30. 30 Naruse K., Naruse M., Watanabe Y. et al. Molecular form of immunoreactive endothelin in plasma and urine of normal subjects and patients with various disease states. J. Cardiovasc. Pharmacol. 1991 ; 17 (Suppl. 7): S506–8.
31. 31 Moore K., Wendon J., Fraezer M., Karani J., Williams R., Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N. Engl. J. Med. 1992 ; 327: 1174–8.
32. 32 Claria J., Jimenez W., Arroyo V. et al. Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. Kidney Int. 1991 ; 40: 182–7.
33. 33 Zeidel ML, Brady HR, Kone BC, Gullans SR, Brenner BM. Endothelin, a peptide inhibitor of Na + ‐K + ‐ATPase in intact renal tubular epithelial cells. Am. J. Physiol. 1989 ; 257: C1101–7.